We will be on-site, come to our booth, check out our products and talk to our experts!
Geneva, Switzerland, Palexpo
September 14 - 15, 2022
Booth # A20
Our highlights:
We will be on-site to showcase our high-quality products made of glass and plastics for the international pharma and healthcare industry. In particular we will present our latest innovations, e.g. the new SensAir On-Body Drug Delivery Device and our new autoinjector.
With our Gx® Ready-To-Fill (RTF) glass vials made of borosilicate glass type I, washed, packed and sterilized for a direct fill, we will present our perfect solution for your medication.
Attend the presentation of our experts:
Patient-focused drug-delivery solutions for subcutaneous injection of large molecule biologics
September 14, 02:15 - 02:45pm
A patient-focused approach is implemented to address subcutaneous administration of large volumes of large-molecule biologics. Furthermore, Patient Preference Information (PPI) is studied both from the regulatory aspect and from the results of two existing clinical studies. In order to address the patient and user needs, we need to focus on SC administration and current landscape of drug delivery solutions for large molecules biologics.
Dr. Reza Abedian, Senior Medical Affairs Manager, Gerresheimer
Reducing your time to market of Injectable drug delivery containment in collaborating early in clinical stage
September 15, 12:00-12:45pm
Pharma & biotech companies focus on research & discovery of molecules, but the delivery system is often forgotten in the development process. In the early stages of clinical development (phase I), it can be beneficial to discuss different packaging options for the targeted patient populations taking into account the challenges associated with the drug molecules (concentration, dose, dry, liquid/liquid, etc…) with the associated manufacturing concerns.
Thus, defining injectable delivery needs and expectations, while simultaneously working with a capable partner, are more than recommended.
Wenzel Novak PhD, Senior Global Director Business Development MDS, Gerresheimer
Jean-Edouard Rabier, Project Management Director & Sales Development Gx Biological Solutions, Gerresheimer
